DIRS.INFO The most relevant business & tech news

☆ A controversial study says intermittent fasting may shorten your lifespan. It shows how little we really know about the long-term effects.
▼ + stars: | 2024-03-18 | by ( ) www.businessinsider.com time to read: +7 min

A new study links intermittent fasting to a higher risk of early death instead of longevity. While there's not yet enough evidence to say intermittent fasting is risky, the findings suggest we may have a lot more to learn about whether it's good for our health in the long run. However, some rigorous studies on intermittent fasting have found mixed results: some suggest it's no better for you than other diets, and isn't worth the side effects like hunger. people who follow the 16:8 diet — would have a lower risk of dying during the study, and better heart health. Advertisement"Overall, this study suggests that time-restricted eating may have short-term benefits but long-term adverse effects," Gardner said in a press release.

Persons: —, there's, Victor Wenze Zhong, Krista Varady, Varady, David Spiegelhalter, Christopher D, Gardner, Zhong Organizations: Service, Shanghai Jiao Tong University School of Medicine, American Heart Association, University of Illinois Chicago, University of Cambridge Locations: Shanghai, China, Chicago, Stanford

☆ Diet and sugary drinks boost risk of atrial fibrillation by up to 20%, study says
▼ + stars: | 2024-03-05 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +6 min

Atrial fibrillation is dangerous and on the riseAtrial fibrillation is the leading cause of stroke in the United States. Atrial fibrillation can also lead to blood clots, heart failure and “can increase the risk for heart attack, for dementia, for kidney disease. Replacing both diet and added sugar sodas with water is best to reduce chances of atrial fibrillation, experts say. The rate of atrial fibrillation in the US population is growing: The CDC estimates some 12 million Americans will have A-fib by 2030. “Do not take it for granted that drinking low-sugar and low-calorie artificially sweetened beverages is healthy, it may pose potential health risks.”

Persons: ”, Penny Kris, Etherton, Kris, “, Dr, Gregory Marcus, ” Marcus, Naveed Sattar, ” Sattar, Ningjian Wang, ” Wang Organizations: CNN, Pennsylvania State University, American Heart Association, US Centers for Disease Control, University of California, San Francisco School of Medicine, UCSF Health, Rhythm Society, University of Glasgow, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine Locations: United States, Scotland, Shanghai, China

☆ China opens the world's deepest and largest underground laboratory 7,800 feet below a mountain to hunt for dark matter
▼ + stars: | 2024-01-23 | by ( Marianne Guenot | ) www.businessinsider.com time to read: +4 min

China has just opened the deepest and largest underground laboratory in the world. AdvertisementChina has opened the biggest and deepest underground laboratory in the world in a bid to uncover the secrets of dark matter. That leaves us with one overarching theory; that there is another type of matter acting on the universe, or so-called dark matter. CJPL hosts the Particle and Astrophysical Xenon Experiments (PandaX) and the China Dark Matter Experiment. "There is enough replication already," he said, adding that it may be better to try to find a new approach in the hunt for dark matter.

Persons: —, Gran, Ning Zhao, Juan Collar Organizations: Service, Gran Sasso National Laboratory, Nature News, Nature, Sanford Underground Research, Shanghai Jiao Tong, University of Chicago Locations: China, China's Sichuan Province, CJPL, Sichuan, Italy, , South Dakota, Shanghai, Shanghai Jiao Tong University, Illinois

☆ Hybrid vehicle sales surge in China, posing fresh threat to foreign automakers
▼ + stars: | 2023-11-21 | by ( ) www.reuters.com time to read: +6 min

A Li L7 electric SUV by Li Auto is displayed at the Auto Shanghai show, in Shanghai, China April 18, 2023. One-third of total vehicle sales by Toyota, the world's top-selling automaker, are already hybrids and the company reported a 34% surge in hybrid sales in the six months to end-September, outpacing 9% growth in overall revenue. Sales of HEVs in China, which Toyota still dominates with four top-selling models, tumbled 15%, while gasoline car sales dropped 11%, underscoring potential challenges facing foreign automakers. But it was a failed trial, with sales of just over 4,000 units, and GM in 2020 halted sales. BYD is expanding PHEV sales overseas, offering Han, Qin and Song lineups in Latin America, which has less charging infrastructure.

Persons: Li Auto, Aly, Xu Min, Yale Zhang, BYD, Li, Han, Qin, Stellantis, Leapmotor, Xu, Bill Russo, Zhang Yan, Brenda Goh, Miyoung Kim, Gerry Doyle Organizations: Li, Auto, REUTERS, Rights, Toyota, Honda, Shanghai Jiao Tong University's Institute, Intelligent, Reuters, China Association of Automobile Manufacturers, HK, Automotive Foresight, Reuters Graphics, Prius, General Motors, Buick, GM, Li Auto, Jiao Tong University, HEVs, Thomson Locations: Auto Shanghai, Shanghai, China, Europe, U.S, outpacing, United States, Shanghai Jiao, Reuters Graphics CHINA, America, Leapmotor, North America

☆ With record youth unemployment, China’s jobs market is getting tougher for new graduates to crack
▼ + stars: | 2023-08-03 | by ( Evelyn Cheng | ) www.cnbc.com time to read: +5 min

The unemployment rate for young people ages 16 to 24 in China has soared to record highs above 20% in May and April. Many requested anonymity since youth unemployment can be a sensitive topic in China, especially for those in the middle of a job search or just starting a career. watch nowThe unemployment rate for China's young people ages 16 to 24 climbed to a new record high in June of 21.3%. Youth unemployment has remained persistently high over the last three years, while the overall jobless rate for people in cities has officially stayed far lower, near 5%. Zhang expects the unemployment rate for young people to drop toward the end of the year, after the summer graduation season.

Persons: Kevin Frayer, Zhang Chenggang, —, Zhang, Cheung, Caixin, Sun, “ Organizations: Getty, BEIJING, CNBC, Shanghai Jiao Tong University, Huawei, U.S . News, Capital University of Economics, Business, U.S . Bureau of Labor Statistics, Cheung Kong Graduate School of Business Locations: China, Shanghai, U.S, Beijing

March 17 (Reuters) - Huawei Technologies Co Ltd's (HWT.UL) founder said that the company has replaced more than 13,000 parts in its products that were hit by U.S. trade sanctions, according to a transcript of a speech posted on Friday by a Chinese university. According to the transcript posted by Shanghai Jiao Tong University, Huawei founder Ren Zhengfei said Huawei had over the past three years replaced the 13,000 components with domestic Chinese substitutes and had redesigned 4,000 circuit boards for it products. He said production of circuit boards had "stabilized." The university posted the transcript on its website on Friday. Ren said Huawei invested $23.8 billion in R&D in 2022, and "as our profitability improves, we'll continue to increase R&D spending."

☆ A promising new Covid pill shows key advantages over Paxlovid in trial
▼ + stars: | 2022-12-30 | by ( Aria Bendix | ) www.cnbc.com time to read: +2 min

A new antiviral pill for Covid was found to be as effective as Paxlovid at curbing mild to moderate illness among people at high risk of severe disease in a Phase 3 trial in China. The results, published Wednesday in The New England Journal of Medicine, suggest that the treatment had fewer side effects than Paxlovid, the go-to antiviral for high-risk patients. Around 67% of people who took the experimental pill, called VV116, reported side effects, compared to to 77% who took Paxlovid. In the trial of VV116, more than 380 people took the experimental drug, while a similarly sized group took Paxlovid. The median time to recovery — defined as no Covid symptoms for two consecutive days — was four days for VV116 recipients and five days for those who took Paxlovid.

Around 67% of people who took the experimental pill, called VV116, reported side effects, compared to to 77% who took Paxlovid. In the trial of VV116, more than 380 people took the experimental drug, while a similarly sized group took Paxlovid. The median time to recovery — defined as no Covid symptoms for two consecutive days — was four days for VV116 recipients and five days for those who took Paxlovid. Three-quarters of the trial participants were vaccinated, though the study found consistent results regardless of vaccine status. The National Institutes of Health recommends Paxlovid, with molnupiravir as an alternative in situations when neither Paxlovid nor remdesivir is available or appropriate.

Search resuls for: "Shanghai Jiao Tong University"

8 mentions found